Great Basin Corporation Secures $9.5 Million in Series B Funding
1/7/2013 8:09:44 AM
More...
|
Great Basin Corporation Opens New, Expanded Manufacturing Facility to Meet Market Demand for Low-Cost, Easy-to-Use Molecular Diagnostics Tests
11/13/2012 9:10:33 AM
More...
|
Study Published in Journal of Clinical Microbiology Reports the Sensitivity and Specificity of Great Basin Corporation’s Clostridium difficile Molecular Diagnostic Test
8/13/2012 2:51:39 PM
More...
|
Great Basin Corporation Launches U.S. and Global Sales Efforts
7/10/2012 10:13:22 AM
More...
|
Great Basin Corporation’s TB ID/R Molecular Diagnostic Test Detects Mycobacterium Tuberculosis with 96 Percent Accuracy According to Study Published in Journal of Clinical Microbiology
7/2/2012 9:41:12 AM
More...
|
Data Presented at the American Society of Microbiology General Meeting Demonstrates Specificity of Great Basin Corporation's Candida Molecular Diagnostic Test
6/20/2012 11:21:02 AM
More...
|
Great Basin Corporation Receives FDA 510(k) Approval for C. Difficile Molecular Diagnostic Test
5/1/2012 7:24:19 AM
More...
|
Journal of Clinical Microbiology Publishes Study Demonstrating Accuracy and Specificity of Great Basin Corporation's Staph ID/R Molecular Diagnostic Test
2/23/2012 9:20:42 AM
More...
|
Great Basin Corporation Submits 510(K) Application to FDA for C. Difficile Molecular Diagnostic Test
11/14/2011 8:06:40 AM
More...
|
Great Basin Corporation Initiates First Clinical Trial for C. Difficile Molecular Diagnostic Test
6/28/2011 9:22:49 AM
More...
|